脑膜中动脉栓塞作为慢性硬膜下血肿手术清除围手术期辅助手段的顺序与时机:一项多中心研究
这项多中心回顾性研究纳入2018年9月至2023年9月美国10个中心连续接受脑膜中动脉栓塞(MMAE)辅助手术清除的慢性硬膜下血肿患者,比较MMAE在手术前或术后进行的临床与影像结果。倾向性评分匹配后,两组在再手术率和技术成功率上均无显著差异,术后2天内与3-7天行MMAE也无显著差异;作者指出需要更大规模研究来确认这些观察并排除较小的临床有意义差异。
要点
- 匹配后手术前与术后MMAE的再手术率分别为8% vs 4%,技术成功率100% vs 98%,均无显著差异。
- 术后2天内与3-7天行MMAE的再手术率分别为6% vs 8%,技术成功率98% vs 100%,均无显著差异。
- 未匹配分析对顺序和时机的再手术差异检测效能不足,匹配分析效能更低。
核心结论
- 该队列未显示MMAE相对于手术清除的时机和顺序在技术成功率或再手术率上有统计学显著差异,但需要更大规模研究来确认这些观察并排除较小的临床有意义差异。
研究设计与样本
- 多中心回顾性研究,纳入2018年9月至2023年9月美国10个中心连续接受MMAE辅助手术治疗的慢性硬膜下血肿患者,共266例MMAE操作(237例患者,中位年龄73岁,IQR 65-80岁,175例男性占73.8%),采用倾向性评分匹配平衡基线特征,使用χ2检验和Mann-Whitney U检验。
诊断标准与关键数值
- 倾向性评分匹配后,手术前MMAE组再手术4/48(8%)vs 手术后MMAE组4/93(4%),P=0.90。
- 倾向性评分匹配后,手术前MMAE组技术成功48/48(100%)vs 手术后MMAE组91/93(98%),P=0.31。
- 倾向性评分匹配后,术后2天内MMAE组再手术3/52(6%)vs 术后3-7天MMAE组3/37(8%),P=0.67。
- 倾向性评分匹配后,术后2天内MMAE组技术成功51/52(98%)vs 术后3-7天MMAE组37/37(100%),P=0.40。
局限性
- 未匹配分析对顺序和时机的再手术差异检测效能不足,无法检测低于11.6%和14.6%的差异;对技术成功差异检测效能不足,无法检测低于8.5%和11.3%的差异,匹配分析效能更低。
- 需要更大规模研究来确认这些观察并排除较小的临床有意义差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Chronic subdural hematoma (cSDH) is a common neurosurgical condition, and middle meningeal artery embolization (MMAE) has emerged as a minimally invasive adjunct to surgery, but optimal timing remains unclear. Purpose To investigate radiographic and clinical outcomes of patients with cSDH undergoing MMAE as an adjunct to surgical evacuation, focusing on order and timing of MMAE relative to surgery. Materials and Methods This multicenter, retrospective study included consecutive patients undergoing MMAE adjunct to surgery for cSDH at 10 U.S. centers from September 2018 to September 2023. Clinical and radiographic characteristics and outcomes were examined in MMAE before or after surgery. Primary outcomes included recurrence requiring reoperation and technical success of MMAE. Secondary outcomes included radiographic success, rate of change in hematoma thickness, and functional outcome. Propensity score matching (PSM) balanced baseline characteristics. χ2 and Mann-Whitney U tests were used. Results Of the 266 MMAE procedures included in the study (237 patients; median age, 73 years [IQR, 65-80 years]; 175 [73.8%] male), 85 (32.0%) were performed before surgery and 181 (68.0%) were performed after surgery. After PSM, no evidence of differences was found in reoperation (8% [four of 48] vs 4% [four of 93]; P = .90) or technical success (100% [48 of 48] vs 98% [91 of 93]; P = .31) between groups. Similarly, no evidence of differences was observed between MMAE performed within 2 days or 3-7 days after surgery in PSM analysis in reoperation (6% [three of 52] vs 8% [three of 37], respectively; P = .67) or procedural success (98% [51 of 52] vs 100% [37 of 37], respectively; P = .40). The unmatched analysis for order and timing was underpowered to detect differences in reoperation below 11.6% and 14.6%, respectively, and in technical success below 8.5% and 11.3%, respectively, and the matched analyses were more underpowered. Conclusion The cohort did not show statistically significant differences in technical success or reoperation rates based on the timing and order of MMAE relative to surgical evacuation, although larger studies are needed to confirm these observations and rule out smaller, clinically meaningful differences. © RSNA, 2025 Supplemental material is available for this article.
引用
- Sioutas GS, Salem MM, Kuybu O, et al. Order and Timing of Middle Meningeal Artery Embolization as a Perioperative Adjunct to Surgical Evacuation for Chronic Subdural Hematomas: A Multicenter Study. Radiology. 2025. PMID: 40298598. doi:10.1148/radiol.241571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。